2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing

Bruce L Wilkoff, Laurent Fauchier, Martin K Stiles, Carlos A Morillo, Sana M Al-Khatib, Jesœs Almendral, Luis Aguinaga, Ronald D Berger, Alejandro Cuesta, James P Daubert, Sergio Dubner, Kenneth A Ellenbogen, N A Mark Estes 3rd, Guilherme Fenelon, Fermin C Garcia, Maurizio Gasparini, David E Haines, Jeff S Healey, Jodie L Hurtwitz, Roberto Keegan, Christof Kolb, Karl-Heinz Kuck, Germanas Marinskis, Martino Martinelli, Mark McGuire, Luis G Molina, Ken Okumura, Alessandro Proclemer, Andrea M Russo, Jagmeet P Singh, Charles D Swerdlow, Wee Siong Teo, William Uribe, Sami Viskin, Chun-Chieh Wang, Shu Zhang, Bruce L Wilkoff, Laurent Fauchier, Martin K Stiles, Carlos A Morillo, Sana M Al-Khatib, Jesœs Almendral, Luis Aguinaga, Ronald D Berger, Alejandro Cuesta, James P Daubert, Sergio Dubner, Kenneth A Ellenbogen, N A Mark Estes 3rd, Guilherme Fenelon, Fermin C Garcia, Maurizio Gasparini, David E Haines, Jeff S Healey, Jodie L Hurtwitz, Roberto Keegan, Christof Kolb, Karl-Heinz Kuck, Germanas Marinskis, Martino Martinelli, Mark McGuire, Luis G Molina, Ken Okumura, Alessandro Proclemer, Andrea M Russo, Jagmeet P Singh, Charles D Swerdlow, Wee Siong Teo, William Uribe, Sami Viskin, Chun-Chieh Wang, Shu Zhang

No abstract available

Keywords: AF, atrial fibrillation; ATP, antitachycardia pacing; Bradycardia mode and rate; CI, confidence interval; CL, cycle length; CRT, cardiac resynchronization therapy; CRT-D, cardiac resynchronization therapy–defibrillator; DT, defibrillation testing; Defibrillation testing; EEG, electroencephalography; EGM, electrogram; HF, heart failure; HR, hazard ratio; ICD, implantable cardioverter-defibrillator; Implantable cardioverter-defibrillator; LV, left ventricle; LVEF, left ventricular ejection fraction; MI, myocardial infarction; MVP, managed ventricular pacing; NCDR, National Cardiovascular Data Registry; NYHA, New York Heart Association; OR, odds ratio; PEA, peak endocardial acceleration; PVC, premature ventricular contraction; Programming; RCT, randomized clinical trial; RV, right ventricle; S-ICD, subcutaneous implantable cardioverter-defibrillator; SCD, sudden cardiac death; SVT, supraventricular tachycardia; TIA, transient ischemic attack; Tachycardia detection; Tachycardia therapy; VF, ventricular fibrillation; VT, ventricular tachycardia (Heart Rhythm 2015;0:1–37); aCRT, adaptive cardiac resynchronization therapy.

References

    1. Jacobs A.K., Anderson J.L., Halperin J.L. The evolution and future of ACC/ AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation. 2014;130(14):1208–1217. Sep 30.
    1. Anderson J.L. Evolution of the ACC/AHA Clinical Practice Guidelines in Perspective. J Am Coll Cardiol. 2015;65(25):2735–2738.
    1. Nielsen J.C., Thomsen P.E.B., Hojberg S. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. Eur Heart J. 2011;32(6):686–696.
    1. Connolly S.J., Kerr C.R., Gent M. Effects of Physiologic Pacing versus Ventricular Pacing on the Risk of Stroke and Death Due to Cardiovascular Causes. N Engl J Med. 2000;342(19):1385–1391.
    1. Lamas G.A., Lee K.L., Sweeney M.O. Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node Dysfunction. N Engl J Med. 2002;346(24):1854–1862.
    1. Lamas G.A., Orav E.J., Stambler B.S. Quality of Life and Clinical Outcomes in Elderly Patients Treated with Ventricular Pacing as Compared with Dual- Chamber Pacing. N Engl J Med. 1998;338(16):1097–1104.
    1. Toff W.D., Camm A.J., Skehan J.D. Single-Chamber versus Dual-Chamber Pacing for High-Grade Atrioventricular Block. N Engl J Med. 2005;353(2):145–155.
    1. Healey J.S. Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing: Meta-Analysis of Randomized Trials, Using Individual Patient Data. Circulation. 2006;114(1):11–17.
    1. Castelnuovo E., Stein K., Pitt M., Garside R., Payne E. The effectiveness and cost- effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. Health Technol Assess. 2005;9(43):1–246. iii, xi-xiii.
    1. Theuns D.A., Klootwijk A.P., Goedhart D.M., Jordaens L.J. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol. 2004;44(12):2362–2367.
    1. Chen B.W., Liu Q., Wang X., Dang A.M. Are dual-chamber implantable cardioverter-defibrillators really better than single-chamber ones? A systematic review and meta-analysis. J Interv Card Electrophysiol. 2014;39(3):273–280.
    1. Wilkoff B.L., Cook J.R., Epstein A.E. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial JAMA. 2002;288(24):3115–3123.
    1. Wilkoff B.L., Kudenchuk P.J., Buxton A.E. The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial. J Am Coll Cardiol. 2009;53(10):872–880. Mar 10.
    1. Castelnuovo E., Stein K., Pitt M., Garside R., Payne E. The effectiveness and cost- effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. Health Technol Assess. 2005;9(43) 11 2005.
    1. Magrì D., Corrà U., Di Lenarda A. Cardiovascular mortality and chronotropic incompetence in systolic heart failure: the importance of a reappraisal of current cut-off criteria. Eur J Heart Fail. 2013/2017;16(2):201–209.
    1. Sims D.B., Mignatti A., Colombo P.C. Rate responsive pacing using cardiac resynchronization therapy in patients with chronotropic incompetence and chronic heart failure. Europace. 2011;13(10):1459–1463.
    1. Padeletti L., Pieragnoli P., Di Biase L. Is a Dual-Sensor Pacemaker Appropriate in Patients with Sino-Atrial Disease? Results from the DUSISLOG Study. Pacing Clin Electrophysiol. 2006;29(1):34–40.
    1. Sulke N., Chambers J., Dritsas A., Sowton E. A randomized double-blind crossover comparison of four rate-responsive pacing modes. J Am Coll Cardiol. 1991;17(3):696–706.
    1. Lamas G.A., Knight J.D., Sweeney M.O. Impact of rate-modulated pacing on quality of life and exercise capacity—Evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT) Heart Rhythm. 2007;4(9):1125–1132.
    1. Lau C.P., Rushby J., Leigh-Jones M. Symptomatology and quality of life in patients with rate-responsive pacemakers: A double-blind, randomized, crossover study. Clin Cardiol. 1989;12(9):505–512.
    1. Oto M.A., Muderrisoglu H., Ozin M.B. Quality of Life in Patients with Rate Responsive Pacemakers: A Randomized, Cross-Over Study. Pacing Clin Electrophysiol. 1991;14(5):800–806.
    1. Dell’Orto S., Valli P., Greco E.M. Sensors for rate responsive pacing. Indian Pacing Electrophysiol J. 2004;4(3):137–145.
    1. Martin D.O., Day J.D., Lai P.Y. Atrial support pacing in heart failure: results from the multicenter PEGASUS CRT trial. J Cardiovasc Electrophysiol. 2012;23(12):1317–1325.
    1. Leung S.-K., Lau C.-P. DEVELOPMENTS IN SENSOR-DRIVEN PACING. Cardiol Clin. 2000;18(1):133–155.
    1. Van Campen LCMC De Cock C.C., Visser F.C., Visser C.A. The Effect of Rate Responsive Pacing in Patients with Angina Pectoris on the Extent of Ischemia on 201-Thallium Exercise Scintigraphy. Pacing Clin Electrophysiol. 2002;25(4):430–434.
    1. Brignole M., Auricchio A., Baron-Esquivias G. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) Eur Heart J. 2013;34(29):2281–2329.
    1. Geelen P., Brugada J., Andries E., Brugada P. Ventricular Fibrillation and Sudden Death After Radiofrequency Catheter Ablation of the Atrioventricular Junction. Pacing Clin Electrophysiol. 1997;20(2):343–348.
    1. Nowinski K., Gadler F., Jensen-Urstad M., Bergfeldt L. Transient proarrhythmic state following atrioventricular junction radiofrequency ablation: pathophysiologic mechanisms and recommendations for management. Am J Med. 2002;113(7):596–602.
    1. Andersen H.R., Nielsen J.C., Thomsen P.E.B. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. The Lancet. 1997;350(9086):1210–1216.
    1. Sweeney M.O. Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction. Circulation. 2003;107(23):2932–2937.
    1. The DTI Dual-Chamber Pacing or Ventricular Backup Pacing in Patients With an Implantable Defibrillator. JAMA. 2002;288(24):3115.
    1. Sharma A.D., Rizo-Patron C., Hallstrom A.P. Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm. 2005;2(8):830–834.
    1. Olshansky B., Day J.D., Moore S. Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study. Circulation. 2007;115(1):9–16. Jan 2.
    1. Steinberg J.S., Fischer A.V.I., Wang P. The Clinical Implications of Cumulative Right Ventricular Pacing in the Multicenter Automatic Defibrillator Trial II. J Cardiovasc Electrophysiol. 2005;16(4):359–365.
    1. Smit M.D., PFHM Van Dessel, Nieuwland W. Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients. Heart Rhythm. 2006;3(12):1397–1403.
    1. Gillis A.M., Purerfellner H., Israel C.W. Reducing Unnecessary Right Ventricular Pacing with the Managed Ventricular Pacing Mode in Patients with Sinus Node Disease and AV Block. Pacing Clin Electrophysiol. 2006;29(7):697–705.
    1. Kolb C., Schmidt R., Dietl J.U. Reduction of Right Ventricular Pacing with Advanced Atrioventricular Search Hysteresis: Results of the PREVENT Study. Pacing Clin Electrophysiol. 2011;34(8):975–983.
    1. Akerström F., Arias M.A., Pachón M., Puchol A., JimØnez-López J., Rodríguez- Padial L. The reverse mode switch algorithm: How well does it work? Heart Rhythm. 2013;10(8):1146–1152.
    1. PüRerfellner H., Brandt J., Israel C. Comparison of Two Strategies to Reduce Ventricular Pacing in Pacemaker Patients. Pacing Clin Electrophysiol. 2008;31(2):167–176.
    1. Murakami Y., Tsuboi N., Inden Y. Difference in percentage of ventricular pacing between two algorithms for minimizing ventricular pacing: results of the IDEAL RVP (Identify the Best Algorithm for Reducing Unnecessary Right Ventricular Pacing) study. Europace. 2009;12(1):96–102.
    1. Sweeney M.O., Bank A.J., Nsah E. Minimizing Ventricular Pacing to Reduce Atrial Fibrillation in Sinus-Node Disease. N Engl J Med. 2007;357(10):1000–1008.
    1. Sweeney M.O., Ellenbogen K.A., Tang A.S.L. Atrial pacing or ventricular backup–only pacing in implantable cardioverter-defibrillator patients. Heart Rhythm. 2010;7(11):1152–1560.
    1. Steinbach M., Douchet M.-P., Bakouboula B., Bronner F., Chauvin M. Outcome of patients aged over 75 years who received a pacemaker to treat sinus node dysfunction. Arch Cardiovasc Dis. 2011;104(2):89–96.
    1. Veasey R.A., Arya A., Silberbauer J. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study. Europace. 2011;13(6):815–820.
    1. Rey J.-L., Quenum S., Hero M. Effect of a Pacing Mode Preserving Spontaneous AV Conduction on Ventricular Pacing Burden and Atrial Arrhythmias. Pacing Clin Electrophysiol. 2012;35(5):580–585.
    1. L. Botto G., Ricci R.P., BØnØzet J.M. Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: Results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study. Heart Rhythm. 2014;11(6):992–1000.
    1. Boriani G., Tukkie R., Manolis A.S. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial. Eur Heart J. 2014;35(35):2352–2362.
    1. Chen S., Chen K., Tao Q. Reduction of unnecessary right ventricular pacing by managed ventricular pacing and search AV+ algorithms in pacemaker patients: 12-month follow-up results of a randomized study. Europace. 2014;16(11):1595–1602.
    1. Gillis A.M., Russo A.M., Ellenbogen K.A. HRS/ACCF Expert Consensus Statement on Pacemaker Device and Mode Selection. Heart Rhythm. 2012;9(8):1344–1365.
    1. Nielsen J.C., Thomsen P.E.B., Hojberg S. Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing. Europace. 2011;14(5):682–689.
    1. Den Dulk K., Lindemans F.W., Brugada P., Smeets J.L.R.M., Wellens H.J.J. Pacemaker Syndrome with AAI Rate Variable Pacing: Importance of Atrioventricular Conduction Properties, Medication, and Pacemaker Programmability. Pacing Clin Electrophysiol. 1998;11(11):1226–1233.
    1. Sweeney M.O. Novel Cause of Spurious Mode Switching in Dual-Chamber Pacemakers: Atrioventricular Desynchronization Arrhythmia. J Cardiovasc Electrophysiol. 2002;13(6):616–619.
    1. Pascale P., Pruvot E., Graf D. Pacemaker Syndrome During Managed Ventricular Pacing Mode: What is the Mechanism? J Cardiovasc Electrophysiol. 2009;20(5):574–576.
    1. Sweeney M.O., Ruetz L.L., Belk P., Mullen T.J., Johnson J.W., Sheldon T. Bradycardia Pacing-Induced Short-Long-Short Sequences at the Onset of Ventricular Tachyarrhythmias. J Am Coll Cardiol. 2007;50(7):614–622.
    1. Vavasis C., Slotwiner D.J., Goldner B.G., Cheung J.W. Frequent Recurrent Polymorphic Ventricular Tachycardia during Sleep Due to Managed Ventricular Pacing. Pacing Clin Electrophysiol. 2009;33(5):641–644.
    1. Sweeney M.O., Ellenbogen K.A., Tang A.S.L., Johnson J., Belk P., Sheldon T. Severe Atrioventricular Decoupling, Uncoupling, and Ventriculoatrial Coupling During Enhanced Atrial Pacing: Incidence, Mechanisms, and Implications for Minimizing Right Ventricular Pacing in ICD Patients. J Cardiovasc Electrophysiol. 2008;19(11):1175–1180.
    1. Gersh B.J., Maron B.J., Bonow R.O. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124(24):2761–2796.
    1. Nishimura R.A., Hayes D.L., Ilstrup D.M., Holmes D.R., Jamil Tajik A. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy Acute doppler echocardiographic and catheterization hemodynamic study. J Am Coll Cardiol. 1996;27(2):421–430.
    1. Topilski I., Sherez J., Keren G., Copperman I. Long-Term Effects of Dual- Chamber Pacing With Periodic Echocardiographic Evaluation of Optimal Atrioventricular Delay in Patients With Hypertrophic Cardiomyopathy >50 Years of Age. Am J Cardiol. 2006;97(12):1769–1775.
    1. Moss A.J., Hall W.J., Cannom D.S. Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events. N Engl J Med. 2009;361(14):1329–1338.
    1. Tang A.S.L., Wells G.A., Talajic M. Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure. N Engl J Med. 2010;363(25):2385–2395.
    1. Chen S., Ling Z., Kiuchi M.G., Yin Y., Krucoff M.W. The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients. Europace. 2013;15(7):992–1001.
    1. Koplan B.A., Kaplan A.J., Weiner S., Jones P.W., Seth M., Christman S.A. Heart Failure Decompensation and All-Cause Mortality in Relation to Percent Biventricular Pacing in Patients With Heart Failure. J Am Coll Cardiol. 2009;53(4):355–360.
    1. Hayes D.L., Boehmer J.P., Day J.D. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm. 2011;8(9):1469–1475.
    1. Gasparini M., Auricchio A., Regoli F. Four-Year Efficacy of Cardiac Resynchronization Therapy on Exercise Tolerance and Disease Progression. J Am Coll Cardiol. 2006;48(4):734–743.
    1. Ousdigian K.T., Borek P.P., Koehler J.L., Heywood J.T., Ziegler P.D., Wilkoff B.L. The Epidemic of Inadequate Biventricular Pacing in Patients With Persistent or Permanent Atrial Fibrillation and Its Association With Mortality. Circulation: Arrhythmia Electrophysiol. 2014;7(3):370–376.
    1. Ruwald A.C., Kutyifa V., Ruwald M.H. The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling. Eur Heart J. 2014;36(7):440–448.
    1. Mullens W., Grimm R.A., Verga T. Insights From a Cardiac Resynchronization Optimization Clinic as Part of a Heart Failure Disease Management Program. J Am Coll Cardiol. 2009;53(9):765–773.
    1. Ellenbogen K.A., Gold M.R., Meyer T.E. Primary Results From the SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV) Trial: A Randomized Trial Comparing Empirical, Echocardiography-Guided, and Algorithmic Atrioventricular Delay Programming in Cardiac Resynchronization Therapy. Circulation. 2010;122(25):2660–2668.
    1. Abraham W.T., Gras D., Yu C.M., Guzzo L., Gupta M.S. Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: The Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial. Am Heart J. 2010;159(6):944–948.
    1. Bax J.J., Gorcsan J. Echocardiography and Noninvasive Imaging in Cardiac Resynchronization Therapy. J Am Coll Cardiol. 2009;53(21):1933–1943.
    1. Thibault B., Ducharme A., Harel F. Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex >/=120 milliseconds. Circulation. 2011;124(25):2874–2881. Dec 20.
    1. Martin D.O., Lemke B., Birnie D. Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: Results of the adaptive CRT trial. Heart Rhythm. 2012;9(11):1807–1814.
    1. Ritter P., Delnoy P.P.H., Padeletti L. A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. Europace. 2012;14(9):1324–1333.
    1. Lown B. Implanted Standby Defibrillators. Circ. 1972;46:637.
    1. Mirowski M., Reid P.R., Mower M.M. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303(6):322–324. Aug 7.
    1. Gradaus R., Bode-Schnurbus L., Weber M. Effect of ventricular fibrillation duration on the defibrillation threshold in humans. Pacing Clin Electrophysiol. 2002;25(1):14–19.
    1. Moss A.J., Zareba W., Hall W.J. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877–883. Mar 21.
    1. Moss A.J., Hall W.J., Cannom D.S. Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia. N Engl J Med. 1996;335(26):1933–1940.
    1. Bardy G.H., Lee K.L., Mark D.B. Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure. N Engl J Med. 2005;352(3):225–237.
    1. Klein R.C., Raitt M.H., Wilkoff B.L. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol. 2003;14(9):940–948.
    1. Daubert J.P., Zareba W., Cannom D.S. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51(14):1357–1365. Apr 8.
    1. Poole J.E., Johnson G.W., Hellkamp A.S. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359(10):1009–1017. Sep 4.
    1. Grimm W., Flores B.T., Marchlinski F.E. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy. Circulation. 1993;87(6):1880–1888.
    1. Luderitz B., Jung W., Deister A., Marneros A., Manz M. Patient acceptance of the implantable cardioverter defibrillator in ventricular tachyarrhythmias. Pacing Clin Electrophysiol. 1993;16(9):1815–1821.
    1. Rosenqvist M., Beyer T., Block M., den Dulk K., Minten J., Lindemans F. Adverse Events With Transvenous Implantable Cardioverter-Defibrillators: A Prospective Multicenter Study. Circ. 1998;98(7):663–670.
    1. Gold M.R., Peters R.W., Johnson J.W., Shorofsky S.R. Complications Associated with Pectoral Implantation of Cardioverter Defibrillators. Pacing Clin Electrophysiol. 1997;20(1):208–211.
    1. Kron J. Clinical significance of device-related complications in clinical trials and implications for future trials: Insights from the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Card Electrophysiol Rev Cardiovasc Med. 2003;7:473–478.
    1. Schron E.B., Exner D.V., Yao Q. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002;105(5):589–594.
    1. Vollmann D., Luthje L., Vonhof S., Unterberg C. Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator. Heart Rhythm. 2005;2(3):307–309.
    1. Sweeney M.O., Wathen M.S., Volosin K. Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients: Results From the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) Trial Circ. 2005;111(22):2898–2905.
    1. Pinski S.L., Fahy G.J. The proarrhythmic potential of implantable cardioverter- defibrillators. Circ. 1995;92(6):1651–1664.
    1. Wathen M.S., DeGroot P.J., Sweeney M.O. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation. 2004;110(17):2591–2596. Oct 26.
    1. Wilkoff B.L., Williamson B.D., Stern R.S. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol. 2008;52(7):541–550. Aug 12.
    1. Gasparini M., Menozzi C., Proclemer A., editors. Vol. 30. 2009. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study; pp. 2758–2767. (Eur Heart J).
    1. Moss A.J., Schuger C., Beck C.A. Reduction in Inappropriate Therapy and Mortality through ICD Programming. New Engl J Med. 2012;367(24):2275–2283.
    1. Gasparini M., Proclemer A., Klersy C. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA. 2013;309(18):1903–1911. May 8.
    1. Saeed M., Hanna I., Robotis D. Programming implantable cardioverter- defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study. J Cardiovasc Electrophysiol. 2014;25(1):52–59.
    1. Kloppe A., Proclemer A., Arenal A. Efficacy of long detection interval ICD settings in secondary prevention population: Data from the Advance III trial. Circulation. 2014;130:308–314.
    1. Tan V.H., Wilton S.B., Kuriachan V., Sumner G.L., Exner D.V. Impact of Programming Strategies Aimed at Reducing Nonessential Implantable Cardioverter Defibrillator Therapies on Mortality: A Systematic Review and Meta- Analysis. Circulation: Arrhythmia Electrophysiol. 2014;7(1):164–170.
    1. Wilkoff B.L., Ousdigian K.T., Sterns L.D. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol. 2006;48(2):330–339. Jul 18.
    1. Scott P.A., Silberbauer J., McDonagh T.A., Murgatroyd F.D. The Impact of Prolonged ICD Arrhythmia Detection Times On Outcomes: A Meta-analysis. Heart Rhythm. 2014;11:828–835.
    1. Bansch D., Steffgen F., Gronefeld G. The 1+1 trial: a prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias. Circulation. 2004;110(9):1022–1029.
    1. Clementy N., Pierre B., Lallemand B. Long-term follow-up on high-rate cut- off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction. Europace: Eur pacing, Arrhythm, Card Electrophysiol: J Work groups Card pacing, Arrhythm, Card Cell Electrophysiol Eur Soc Cardiol. 2012;14(7):968–974. Jul.
    1. Kloppe A., Proclemer A., Arenal A. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial. Circulation. 2014;130(4):308–314.
    1. Webber M.R., Stiles M.K. Recommendations for the programming of implantable cardioverter-defibrillators in New Zealand. Heart Lung Circ. 2012;21(12):765–777.
    1. Gard J.J., Friedman P.A. Strategies to Reduce ICD Shocks: The Role of Supraventricular Tachycardia–Ventricular Tachycardia Discriminators. Card Electrophysiol Clin. 2011;3(3):373–387.
    1. Aliot E., Nitzsche R., Ripart A. Arrhythmia detection by dual-chamber implantable cardioverter defibrillators. A review of current algorithms. Eur Jul. 2004;6(4):273–286.
    1. Koneru J.N., Swerdlow C.D., Wood M.A., Ellenbogen K.A. Minimizing inappropriate or “unnecessary” implantable cardioverter-defibrillator shocks: appropriate programming. Circ Arrhythm Electrophysiol. 2011;4(5):778–790.
    1. Mansour F., Khairy P. Programming ICDs in the Modern Era beyond Out-of-the Box Settings. Pacing Clin Electrophysiol. 2011;34(4):506–520.
    1. Swerdlow C., Gillberg J., Khairy P. Sensing and detection. In: Ellenbogen K., Kay G., Lau C., Wilkoff B., editors. Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy. 4th ed. W.B. Saunders Company; Philadelphia: 2011. pp. 56–126.
    1. Brugada J., Mont L., Figueiredo M., Valentino M., Matas M., Navarro-Lopez F. Enhanced detection criteria in implantable defibrillators. J Cardiovasc Electrophysiol. 1998;9(3):261–268.
    1. Weber M., Bocker D., Bansch D. Efficacy and safety of the initial use of stability and onset criteria in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 1999;10(2):145–153.
    1. Swerdlow C.D., Ahern T., Chen P.S. Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol. 1994;24(2):416–424.
    1. Swerdlow C.D., Chen P.S., Kass R.M., Allard J.R., Peter C.T. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered- therapy cardioverter-defibrillator. J Am Coll Cardiol. 1994;23(6):1342–1355.
    1. Stadler R.W., Gunderson B.D., Gillberg J.M. An adaptive interval-based algorithm for withholding ICD therapy during sinus tachycardia. Pacing Clin Electrophysiol. 2003;26(5):1189–1201.
    1. Neuzner J., Pitschner H.F., Schlepper M. Programmable VT detection enhancements in implantable cardioverter defibrillator therapy. Pacing Clin Electrophysiol. 1995;18(3 Pt 2):539–547.
    1. Dorian P., Philippon F., Thibault B. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Heart Rhythm. 2004;1(5):540–547.
    1. Requena-Carrion J., Vaisanen J., Alonso-Atienza F., Garcia-Alberola A., Ramos- Lopez F.J., Rojo-Alvarez J.L. Sensitivity and spatial resolution of transvenous leads in implantable cardioverter defibrillator. IEEE Trans Biomed Eng. 2009;56(12):2773–2781.
    1. Swerdlow C.D., Brown M.L., Lurie K. Discrimination of ventricular tachycardia from supraventricular tachycardia by a downloaded wavelet- transform morphology algorithm: a paradigm for development of implantable cardioverter defibrillator detection algorithms. J Cardiovasc Electrophysiol May. 2002;13(5):432–441.
    1. Theuns D.A., Rivero-Ayerza M., Goedhart D.M., van der Perk R., Jordaens L.J. Evaluation of morphology discrimination for ventricular tachycardia diagnosis in implantable cardioverter-defibrillators. Heart Rhythm Nov. 2006;3(11):1332–1338.
    1. Klein G.J., Gillberg J.M., Tang A. Improving SVT discrimination in single- chamber ICDs: A new electrogram morphology-based algorithm. J Cardiovasc Electrophysiol. 2006;17(12):1310–1319.
    1. Swerdlow C.D., Friedman P.A. Advanced ICD troubleshooting: Part I. Pacing Clin Electrophysiol. 2005;28(12):1322–1346.
    1. Wilkoff B.L., Kuhlkamp V., Volosin K. Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: results and technical considerations. Circulation. 2001;103(3):381–386.
    1. Glikson M., Swerdlow C.D., Gurevitz O.T. Optimal combination of discriminators for differentiating ventricular from supraventricular tachycardia by dual-chamber defibrillators. J Cardiovasc Electrophysiol. 2005;16(7):732–739.
    1. Moss A.J., Schuger C., Beck C.A. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367(24):2275–2283.
    1. Meijer A, Auricchio A, Kurita T., et al. Inappropriate shock rates in patients with single chamber ICDs using a novel suite of detection algorithms. Europace. 152013: ii116-ii117.
    1. Grimm W., Flores B.F., Marchlinski F.E. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 1992;15(11):1667–1673.
    1. Gilliam F.R., Hayes D.L., Boehmer J.P. Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: the ALTITUDE REDUCES study. J Cardiovasc Electrophysiol. 2011;22(9):1023–1029.
    1. Fischer A., Ousdigian K.T., Johnson J.W., Gillberg J.M., Wilkoff B.L. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients. Heart Rhythm. 2012;9(1):24–31.
    1. Volosin K.J., Exner D.V., Wathen M.S., Sherfesee L., Scinicariello A.P., Gillberg J.M. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling. J Cardiovasc Electrophysiol. 2011;22(3):280–289.
    1. Nanthakumar K., Dorian P., Paquette M. Is inappropriate implantable defibrillator shock therapy predictable? J Interv Card Electrophysiol. 2003;8(3):215–220.
    1. Wilkoff B.L., Williamson B.D., Stern R.S. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol. 2008;52(7):541–550.
    1. Weiss R., Knight B.P., Gold M.R. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013;128(9):944–953.
    1. Sullivan R.M., Russo A.M., Berg K.C. Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial. Heart Rhythm. 2012;9(3):351–358.
    1. Auricchio A., Schloss E.J., Kurita T. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter- defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. Heart Rhythm. 2015;12(5):926–936.
    1. Friedman P.A., McClelland R.L., Bamlet W.R. Dual-Chamber Versus Single- Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis: The Detect Supraventricular Tachycardia Study. Circulation. 2006;113(25):2871–2879.
    1. Almendral J., Arribas F., Wolpert C. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial. Europace: Eur pacing, Arrhythm, Card Electrophysiol: J Work groups Card pacing, Arrhythm, Card Cell Electrophysiol Eur Soc Cardiol. 2008;10(5):528–535.
    1. Friedman P.A., Slusser J., Hodge D.O. Prospective Randomized Trial Of Dual Chamber Vs. Single Chamber ICDs To Minimize Shocks In Optimally Programmed Devices. Heart Rhythm. 2012;9(9):1583.
    1. Goncalves J., Pereira T. Inappropriate shocks in patients with ICDs: single chamber versus dual chamber. Arq Bras Cardiol. 2013;101(2):141–148.
    1. Kolb C., Sturmer M., Sick P. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. JACC Heart Fail. 2014;2(6):611–619.
    1. Powell B.D., Asirvatham S.J., Perschbacher D.L. Noise, Artifact, and Oversensing Related Inappropriate ICD Shock Evaluation: ALTITUDE NOISE Study. Pacing Clin Electrophysiol. 2012;35(7):863–869.
    1. Sears S.F., Hauf J.D., Kirian K., Hazelton G., Conti J.B. Posttraumatic stress and the implantable cardioverter-defibrillator patient: what the electrophysiologist needs to know. Circ Arrhythm Electrophysiol. 2011;4(2):242–250.
    1. Swerdlow C.D., Gunderson B.D., Ousdigian K.T. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter- defibrillator leads. Circulation. 2008;118(21):2122–2129.
    1. Ellenbogen K.A., Gunderson B.D., Stromberg K.D., Swerdlow C.D. Performance of Lead Integrity Alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads. Circ Arrhythm Electrophysiol. 2013;6(6):1169–1177.
    1. Cao J., Gillberg J.M., Swerdlow C.D. A fully automatic, implantable cardioverter- defibrillator algorithm to prevent inappropriate detection of ventricular tachycardia or fibrillation due to T-wave oversensing in spontaneous rhythm. Heart Rhythm. 2012;9(4):522–530.
    1. Swerdlow C.D., Sachanandani H., Gunderson B.D., Ousdigian K.T., Hjelle M., Ellenbogen K.A. Preventing overdiagnosis of implantable cardioverter- defibrillator lead fractures using device diagnostics. J Am Coll Cardiol. 2011;57(23):2330–2339. Jun 7.
    1. Swerdlow C.D., Ellenbogen K.A. Implantable cardioverter-defibrillator leads: design, diagnostics, and management. Circulation. 2013;128(18):2062–2071. 2061-2069.
    1. Swerdlow C.D., Gunderson B.D., Ousdigian K.T., Abeyratne A., Sachanandani H., Ellenbogen K.A. Downloadable software algorithm reduces inappropriate shocks caused by implantable cardioverter-defibrillator lead fractures: a prospective study. Circulation. 2010;122(15):1449–1455.
    1. Blanck Z., Axtell K., Brodhagen K. Inappropriate shocks in patients with Fidelis(R) lead fractures: impact of remote monitoring and the lead integrity algorithm. J Cardiovasc Electrophysiol. 2011;22(10):1107–1114.
    1. Gunderson B.D., Gillberg J.M., Wood M.A., Vijayaraman P., Shepard R.K., Ellenbogen K.A. Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure. Heart Rhythm. 2006;3(2):155–162.
    1. .Sprint Fidelisfi Lead Patient Management Recommendations Update: Models 6949, 6948, 6931, 6930. 2011; . Accessed 4/21/2013, 2013.
    1. Gold M.R., Theuns D.A., Knight B.P. Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J Cardiovasc Electrophysiol. 2012;23(4):359–366.
    1. Gold M.R., Weiss R., Theuns D.A. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter- defibrillator. Heart Rhythm. 2014;11(8):1352–1358.
    1. Sweeney M.O., Sherfesee L., DeGroot P.J., Wathen M.S., Wilkoff B.L. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm. 2010;7(3):353–360.
    1. Sood N., Ruwald A.C.H., Solomon S. Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT- CRT. Eur Heart J. 2013;35(2):106–115.
    1. Powell B.D., Saxon L.A., Boehmer J.P. Survival After Shock Therapy in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy- Defibrillator Recipients According to Rhythm Shocked. J Am Coll Cardiol. 2013;62(18):1674–1679.
    1. van Rees J.B., Borleffs C.J.W., de Bie M.K. Inappropriate Implantable Cardioverter-Defibrillator Shocks. J Am Coll Cardiol. 2011;57(5):556–562.
    1. Gasparini M., Proclemer A., Klersy C. Effect of Long-Detection Interval vs Standard-Detection Interval for Implantable Cardioverter-Defibrillators on Antitachycardia Pacing and Shock Delivery. JAMA. 2013;309(18):1903.
    1. GonzÆlez-Enríquez S., Rodríguez-Entem F., Expósito V. Single-chamber ICD, single-zone therapy in primary and secondary prevention patients: the simpler the better? J Interv Card Electrophysiol. 2012;35(3):343–349.
    1. Saeed M., Neason C.G., Razavi M. Programming Antitachycardia Pacing for Primary Prevention in Patients With Implantable Cardioverter Defibrillators: Results From the PROVE Trial. J Cardiovasc Electrophysiol. 2010;21(12):1349–1354.
    1. Sivagangabalan G., Eshoo S., Eipper V.E., Thiagalingam A., Kovoor P. Discriminatory Therapy for Very Fast Ventricular Tachycardia in Patients with Implantable Cardioverter Defibrillators. Pacing Clin Electrophysiol. 2008;31(9):1095–1099.
    1. Schoels W., Steinhaus D., Johnson W.B. Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: Antitachycardia pacing therapy during charging. Heart Rhythm. 2007;4(7):879–885.
    1. Wathen M.S., Sweeney M.O., DeGroot P.J. Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients With Coronary Artery Disease. Circulation. 2001;104(7):796–801.
    1. Gasparini M., Anselme F., Clementy J. BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: The ADVANCE CRT-D Trial. Am Heart J. 2010;159(6):1116–1123. e1112.
    1. Yee R., Birgersdotter-Green U., Belk P., Jackson T., Christensen J., Wathen M.S. The Relationship between Pacing Site and Induction or Termination of Sustained Monomorphic Ventricular Tachycardia by Antitachycardia Pacing. Pacing Clin Electrophysiol. 2010;33(1):27–32.
    1. Anguera I., Dallaglio P., SabatÉ X. The Benefit of a Second Burst Antitachycardia Sequence for Fast Ventricular Tachycardia in Patients with Implantable Cardioverter Defibrillators. Pacing Clin Electrophysiol. 2013;37(4):486–494.
    1. Martins R.P., Blangy H., Muresan L. Safety and efficacy of programming a high number of antitachycardia pacing attempts for fast ventricular tachycardia: a prospective study. Europace. 2012;14(10):1457–1464.
    1. Santini M., Lunati M., Defaye P. Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCE-D) Trial results. J Interv Card Electrophysiol. 2010;27(2):127–135.
    1. Gulizia M.M., Piraino L., Scherillo M. A Randomized Study to Compare Ramp Versus Burst Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: The PITAGORA ICD Trial. Circulation: Arrhythmia Electrophysiol. 2009;2(2):146–153.
    1. Sivagangabalan G., Chik W., Zaman S. Antitachycardia Pacing for Very Fast Ventricular Tachycardia and Low-Energy Shock for Ventricular Arrhythmias in Patients With Implantable Defibrillators. Am J Cardiol. 2013;112(8):1153–1157.
    1. Kanal E., Barkovich A.J., Bell C. ACR guidance document on MR safe practices: 2013. J Magn Reson Imaging. 2013;37(3):501–530.
    1. GuØdon-Moreau L., Kouakam C., Klug D. Decreased Delivery of Inappropriate Shocks Achieved by Remote Monitoring of ICD: A Substudy of the ECOST Trial. J Cardiovasc Electrophysiol. 2014;25(7):763–770.
    1. Camm A.J., Sears S.F., Todaro J.F., Lewis T.S., Sotile W., Conti J.B. Examining the psychosocial impact of implantable cardioverter defibrillators: A literature review. Clin Cardiol. 1999;22(7):481–489.
    1. Sears S.F., Vazquez L.D., Matchett M., Pitzalis M. State-of-the-art: anxiety management in patients with implantable cardioverter defibrillators. Stress Health. 2008;24(3):239–248.
    1. Magyar-Russell G., Thombs B.D., Cai J.X. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: A systematic review. J Psychosom Res. 2011;71(4):223–231.
    1. Kraaier K., Starrenburg A.H., Verheggen R.M., van der Palen J., Scholten M.F. Incidence and predictors of phantom shocks in implantable cardioverter defibrillator recipients. Neth Heart J. 2012;21(4):191–195.
    1. GuØdon-Moreau L., Lacroix D., Sadoul N. A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J. 2013;34(8):605–614.
    1. Ruwald A.C., Schuger C., Moss A.J. Mortality Reduction in Relation to Implantable Cardioverter Defibrillator Programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Circulation: Arrhythmia Electrophysiol. 2014;7(5):785–792.
    1. A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias. N Engl J Med 1997;337(22):1576–1584.
    1. Connolly S. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J. 2000;21(24):2071–2078.
    1. Moss A.J., Cannom D.S., Daubert J.P. Multicenter Automatic Defibrillator Implantation Trial II (MADIT II): Design and Clinical Protocol. Ann Noninvasive Electrocardiol. 1999;4(1):83–91.
    1. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., Hafley G. A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease. N Engl J Med. 1999;341(25):1882–1890.
    1. Kadish A., Dyer A., Daubert J.P. Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy. N Engl J Med. 2004;350(21):2151–2158.
    1. Bardy G.H., Lee K.L., Mark D.B. Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure. N Engl J Med. 2005;352(3):225–237. January 20.
    1. Neuzner J., Pitschner H.F., Huth C., Schlepper M. Effect of Biphasic Waveform Pulse on Endocardial Defibrillation Efficacy in Humans. Pacing Clin Electrophysiol. 1994;17(2):207–212.
    1. Gold M.R., Foster A.H., Shorofsky S.R. Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. Am J Cardiol. 1996;78(5):540–543.
    1. Bardy G.H., Yee R., Jung W. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. J Am Coll Cardiol. 1996;28(2):400–410.
    1. Natale A., Sra J., Axtell K. Preliminary experience with a hybrid nonthoracotomy defibrillating system that includes a biphasic device: Comparison with a standard monophasic device using the same lead system. J Am Coll Cardiol. 1994;24(2):406–412.
    1. Swerdlow C.D. Implantation of Cardioverter Defibrillators Without Induction of Ventricular Fibrillation. Circulation. 2001;103(17):2159–2164.
    1. Russo A.M., Sauer W., Gerstenfeld E.P. Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm. 2005;2(5):456–461.
    1. Kolb C., Tzeis S., Zrenner B. Defibrillation Threshold Testing: Tradition or Necessity? Pacing Clin Electrophysiol. 2009;32(5):570–572.
    1. Healey J.S., Dorian P., Mitchell L.B. Canadian Registry of ICD Implant Testing Procedures (CREDIT): Current Practice, Risks, and Costs of Intraoperative Defibrillation Testing. J Cardiovasc Electrophysiol. 2010;21(2):177–182.
    1. Vischer A.S., Sticherling C., KÜHne M.S., Osswald S., Schaer B.A. Role of Defibrillation Threshold Testing in the Contemporary Defibrillator Patient Population. J Cardiovasc Electrophysiol. 2012;24(4):437–441.
    1. Leong-Sit P., Gula L.J., Diamantouros P. Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation. Am Heart J. 2006;152(6):1104–1108.
    1. Kremers M.S., Hammill S.C., Berul C.I. The National ICD Registry Report: Version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm. 2013;10(4):e59–e65.
    1. de Vries J.W., Bakker P.F.A., Visser G.H., Diephuis J.C., van Huffelen A.C. Changes in Cerebral Oxygen Uptake and Cerebral Electrical Activity During Defibrillation Threshold Testing. Anesth Analg. 1998;87(1):16–20.
    1. Singer I., Edmonds H. Changes in cerebral perfusion during third-generation implantable cardioverter defibrillator testing. Am Heart J. 1994;127(4):1052–1057.
    1. Vroems E.M., Bakker P.F.A., De Vries J.W., Wieneke G.H., Van Huffelen A.C. The impact of repeated short episodes of circulatory arrest on cerebral function. Reassuring electroencephalographic (EEG) findings during defibrillation threshold testing at defibrillator implantation. Electroencephalogr Clin Neurophysiol. 1996;98(4):236–242.
    1. da Silva M.P., Rivetti L.A., LAST Mathias, Cagno G., Matsui C. Impact of Induced Cardiac Arrest on Cognitive Function after Implantation of a Cardioverter- Defibrillator. Braz J Anesthesiol. 2009;59(1):37–45.
    1. Karaoguz R., Altln T., Atbasoglu E.C. Defibrillation Testing and Early Neurologic Outcome. Int Heart J. 2008;49(5):553–563.
    1. Schluter T., Baum H., Plewan A., Neumeier D. Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage. Clin Chem. 2001;47:459–463.
    1. Hasdemir C.A.N., Shah N., Rao A.P. Analysis of Troponin I Levels After Spontaneous Implantable Cardioverter Defibrillator Shocks. J Cardiovasc Electrophysiol. 2002;13(2):144–150.
    1. Hurst T.M., Hinrichs M., Breidenbach C., Katz N., Waldecker B. Detection of myocardial injury during transvenous implantation of automatic cardioverter- defibrillators. J Am Coll Cardiol. 1999;34(2):402–408.
    1. Frame R., Brodman R., Furman S. Clinical Evaluation of the Safety of Repetitive Intraoperative Defibrillation Threshold Testing. Pacing Clin Electrophysiol. 1992;15(6):870–877.
    1. Toh N., Nishii N., Nakamura K. Cardiac Dysfunction and Prolonged Hemodynamic Deterioration After Implantable Cardioverter-Defibrillator Shock in Patients With Systolic Heart Failure. Circulation: Arrhythmia Electrophysiol. 2012;5(5):898–905.
    1. Semmler V., Biermann J., Haller B. ICD Shock, Not Ventricular Fibrillation, Causes Elevation of High Sensitive Troponin T after Defibrillation Threshold Testing—The Prospective, Randomized, Multicentre TropShock- Trial. Plos One. 2015;10(7):e0131570.
    1. Mollerus M., Naslund L. Myocardial stunning following defibrillation threshold testing. J Interv Card Electrophysiol. 2007;19(3):213–216.
    1. Frame R., Brodman R., Gross J.A.Y. Initial Experience with Transvenous Implantable Cardioverter Defibrillator Lead Systems: Operative Morbidity and Mortality. Pacing Clin Electrophysiol. 1993;16(1):149–152.
    1. Cardiac Arrhythmias. J Am Coll Cardiol 2008;51(10s1):A1–A34.
    1. Birnie D., Tung S., Simpson C. Complications associated with defibrillation threshold testing: The Canadian experience. Heart Rhythm. 2008;5(3):387–390.
    1. Healey J.S., Gula L.J., Birnie D.H. A Randomized-Controlled Pilot Study Comparing ICD Implantation with and Without Intraoperative Defibrillation Testing in Patients with Heart Failure and Severe Left Ventricular Dysfunction: A Substudy of the RAFT Trial. J Cardiovasc Electrophysiol. 2012;23(12):1313–1316.
    1. Brignole M., Occhetta E., Bongiorni M.G. Clinical Evaluation of Defibrillation Testing in an Unselected Population of 2,120 Consecutive Patients Undergoing First Implantable Cardioverter-Defibrillator Implant. J Am Coll Cardiol. 2012;60(11):981–987.
    1. Russo A., Andriulli J., Ortman M. Outcome following ICD implantation with versus without defibrillation testing: preliminary results of the Prospective Randomized Test-No Test (TNT) Pilot Study. J Am Coll Cardiol. 2014;63(12):A451.
    1. Healey J.S., Hohnloser S.H., Glikson M. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non- inferiority, randomised controlled trial (SIMPLE) The Lancet. 2015;385(9970):785–791.
    1. Bansch D., Bonnemeier H., Brandt J. Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial. Eur Heart J. 2015
    1. Swerdlow C.D., Russo A.M., Degroot P.J. The Dilemma of ICD Implant Testing. Pacing Clin Electrophysiol. 2007;30(5):675–700.
    1. Smits K., Virag N., Swerdlow C.D. Impact of defibrillation testing on predicted ICD shock efficacy: Implications for clinical practice. Heart Rhythm. 2013;10(5):709–717.
    1. Healey J.S., Brambatti M. Is Defibrillation Testing Necessary for Implantable Transvenous Defibrillators?: Defibrillation Testing Should Not Be Routinely Performed at the Time of Implantable Cardioverter Defibrillator Implantation. Circulation: Arrhythmia Electrophysiol. 2014;7(2):347–351.
    1. Blatt J.A., Poole J.E., Johnson G.W. No Benefit From Defibrillation Threshold Testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) J Am Coll Cardiol. 2008;52(7):551–556.
    1. Ellenbogen K.A., Wood M.A., Stambler B.S., Welch W.J., Damiano R.J. Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias. Am J Cardiol. 1992;70(11):1017–1022.
    1. Baccillieri M.S., Gasparini G., Benacchio L. Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter- defibrillator implantation. The MODALITY study. J Interv Card Electrophysiol. 2015;43(1):45–54.
    1. Russo A.M., Wang Y., Al-Khatib S.M., Curtis J.P., Lampert R. Patient, Physician, and Procedural Factors Influencing the Use of Defibrillation Testing during Initial Implantable Cardioverter Defibrillator Insertion: Findings from the NCDRfi. Pacing Clin Electrophysiol. 2013;36(12):1522–1531.
    1. Gold M.R. Efficacy and Temporal Stability of Reduced Safety Margins for Ventricular Defibrillation: Primary Results From the Low Energy Safety Study (LESS) Circulation. 2002;105(17):2043–2048.
    1. Healey J.S., Birnie D.H., Lee D.S. Defibrillation Testing at the Time of ICD Insertion: An Analysis From the Ontario ICD Registry. J Cardiovasc Electrophysiol. 2010;21(12):1344–1348.
    1. Arnson Y., Suleiman M., Glikson M. Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: Data from the Israeli ICD Registry. Heart Rhythm. 2014;11(5):814–821.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever